Lorraine Thelian Email

Sr. consultant Health Technology . BioMarker Strategies

Current Roles

Employees:
6
Revenue:
$465k
About
BioMarker Strategies is a Baltimore, MD-based cancer diagnostics company developing the novel SnapPath™ live-tumor-cell biomarker testing system to improve the treatment of cancer. This automated, patent-pending system is designed to help pathologists and oncologists predict patient response to chemotherapies and targeted cancer therapeutics, reduce unnecessary surgical biopsies and obtain information on treatment options that is not available using current tumor-cell processing methods.
BioMarker Strategies Address
15601 Crabbs Branch Way
Redland, MD
United States
BioMarker Strategies Email

Past Companies

BioMarker Strategies, LLCSr. consultant Health Technology
KetchumSr. Partner North America
KetchumSr. Partner

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.